From February 5, 2024 to March 31, 2024, the company has repurchased 994,500 shares, representing 1.24% for CNY 19.99 million. With this, the company has completed the repurchase of 994,500 shares, representing 1.24% for CNY 19.99 million under the buyback announced on February 5, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.33 CNY | -1.45% | +0.18% | -38.77% |
1st Jan change | Capi. | |
---|---|---|
-38.77% | 178M | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- 301075 Stock
- News Tibet Duo Rui Pharmaceutical Co., Ltd.
- Tranche Update on Tibet Duo Rui Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on February 5, 2024.